Armata Pharmaceuticals to Present Data at ISSSI 2026 Showing Defined Genetic Diversity in AP-SA02 May Enhance Killing of Certain Staphylococcus aureus Clinical Isolates Cision · Sep 21, 2026
Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers Cision · Sep 19, 2026
AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026 Cision · Sep 19, 2026
U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer Cision · Sep 19, 2026
FibroBiologics Announces Closing of $0.5 Million Private Placement with Chief Scientific Officer Cision · Sep 18, 2026
Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026 Cision · Sep 18, 2026
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France Cision · Sep 18, 2026
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033 Cision · Sep 18, 2026
